<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7359800\results\search\country\results.xml">
  <result pre="urgent use of chloroquine and hydroxychloroquine have been approved by" exact="the United States" post="Food and Drug Administration. The use of an antiviral"/>
  <result pre="use of chloroquine and hydroxychloroquine have been approved by the" exact="United States" post="Food and Drug Administration. The use of an antiviral"/>
  <result pre="as high as 49%, based on a recent epidemiological by" exact="China" post="CDC [20]. In Wuhan, 292 patients with COVID-19 were"/>
  <result pre="different epidemics. Table 2 Country Viral etiology Adverse events References" exact="China" post="COVID-19 None [47] China COVID-19 None [48] China COVID-19"/>
  <result pre="Country Viral etiology Adverse events References China COVID-19 None [47]" exact="China" post="COVID-19 None [48] China COVID-19 Self-limited facial erythema in"/>
  <result pre="events References China COVID-19 None [47] China COVID-19 None [48]" exact="China" post="COVID-19 Self-limited facial erythema in 2/10 patients. No major"/>
  <result pre="facial erythema in 2/10 patients. No major adverse events. [49]" exact="China" post="COVID-19 None [50] South Korea COVID-19 None [51] China"/>
  <result pre="patients. No major adverse events. [49] China COVID-19 None [50]" exact="South Korea" post="COVID-19 None [51] China SARS-CoV None [52] China SARS-CoV"/>
  <result pre="[49] China COVID-19 None [50] South Korea COVID-19 None [51]" exact="China" post="SARS-CoV None [52] China SARS-CoV None [53] China SARS-CoV"/>
  <result pre="[50] South Korea COVID-19 None [51] China SARS-CoV None [52]" exact="China" post="SARS-CoV None [53] China SARS-CoV None [54] Taiwan SARS-CoV"/>
  <result pre="None [51] China SARS-CoV None [52] China SARS-CoV None [53]" exact="China" post="SARS-CoV None [54] Taiwan SARS-CoV None [55] China SARS-CoV"/>
  <result pre="None [52] China SARS-CoV None [53] China SARS-CoV None [54]" exact="Taiwan" post="SARS-CoV None [55] China SARS-CoV None [56] China SARS-CoV"/>
  <result pre="None [53] China SARS-CoV None [54] Taiwan SARS-CoV None [55]" exact="China" post="SARS-CoV None [56] China SARS-CoV None [57] China SARS-CoV"/>
  <result pre="None [54] Taiwan SARS-CoV None [55] China SARS-CoV None [56]" exact="China" post="SARS-CoV None [57] China SARS-CoV None [58] South Korea"/>
  <result pre="None [55] China SARS-CoV None [56] China SARS-CoV None [57]" exact="China" post="SARS-CoV None [58] South Korea MERS-CoV None [59] Guinea"/>
  <result pre="None [56] China SARS-CoV None [57] China SARS-CoV None [58]" exact="South Korea" post="MERS-CoV None [59] Guinea Ebola Nausea, skin erythema, fever."/>
  <result pre="[57] China SARS-CoV None [58] South Korea MERS-CoV None [59]" exact="Guinea" post="Ebola Nausea, skin erythema, fever. No major adverse events."/>
  <result pre="Ebola Nausea, skin erythema, fever. No major adverse events. [60]" exact="China" post="Influenza A (H1N1) None [61] China Influenza A (H1N1)"/>
  <result pre="major adverse events. [60] China Influenza A (H1N1) None [61]" exact="China" post="Influenza A (H1N1) None [62] China Influenza A (H1N1)"/>
  <result pre="A (H1N1) None [61] China Influenza A (H1N1) None [62]" exact="China" post="Influenza A (H1N1) None [63] China Influenza A (H1N1)"/>
  <result pre="A (H1N1) None [62] China Influenza A (H1N1) None [63]" exact="China" post="Influenza A (H1N1) None [64] Because there is no"/>
  <result pre="HIV-1 protease [67]. Another drug, umifenovir, was first developed in" exact="Russia" post="and used in Russia and China for the treatment"/>
  <result pre="drug, umifenovir, was first developed in Russia and used in" exact="Russia" post="and China for the treatment of prophylaxis, infections associated"/>
  <result pre="was first developed in Russia and used in Russia and" exact="China" post="for the treatment of prophylaxis, infections associated with influenza"/>
  <result pre="The highest number of infections was found in seven countries:" exact="the United States" post="(nÂ =Â 2294), France (nÂ =Â 3671), Germany (nÂ"/>
  <result pre="highest number of infections was found in seven countries: the" exact="United States" post="(nÂ =Â 2294), France (nÂ =Â 3671), Germany (nÂ"/>
  <result pre="found in seven countries: the United States (nÂ =Â 2294)," exact="France" post="(nÂ =Â 3671), Germany (nÂ =Â 3675), Spain (nÂ"/>
  <result pre="the United States (nÂ =Â 2294), France (nÂ =Â 3671)," exact="Germany" post="(nÂ =Â 3675), Spain (nÂ =Â 5232), South Korea"/>
  <result pre="=Â 2294), France (nÂ =Â 3671), Germany (nÂ =Â 3675)," exact="Spain" post="(nÂ =Â 5232), South Korea (nÂ =Â 8086), Iran"/>
  <result pre="=Â 3671), Germany (nÂ =Â 3675), Spain (nÂ =Â 5232)," exact="South Korea" post="(nÂ =Â 8086), Iran (nÂ =Â 11,364), and Italy"/>
  <result pre="3675), Spain (nÂ =Â 5232), South Korea (nÂ =Â 8086)," exact="Iran" post="(nÂ =Â 11,364), and Italy (nÂ =Â 17,660). The"/>
  <result pre="South Korea (nÂ =Â 8086), Iran (nÂ =Â 11,364), and" exact="Italy" post="(nÂ =Â 17,660). The number of confirmed cases in"/>
  <result pre="to recover from COVID-19 to confer immunity (Pcrit) Rt &amp;gt;4" exact="Bahrain" post="210 6.64 (5.20, 8.61) 85.0 Slovenia 141 6.38 (4.91,"/>
  <result pre="immunity (Pcrit) Rt &amp;gt;4 Bahrain 210 6.64 (5.20, 8.61) 85.0" exact="Slovenia" post="141 6.38 (4.91, 8.38) 84.3 Qatar 320 5.38 (4.59,"/>
  <result pre="6.64 (5.20, 8.61) 85.0 Slovenia 141 6.38 (4.91, 8.38) 84.3" exact="Qatar" post="320 5.38 (4.59, 6.34) 81.4 Spain 5232 5.17 (4.98,"/>
  <result pre="6.38 (4.91, 8.38) 84.3 Qatar 320 5.38 (4.59, 6.34) 81.4" exact="Spain" post="5232 5.17 (4.98, 5.37) 80.7 Denmark 804 5.08 (4.60,"/>
  <result pre="5.38 (4.59, 6.34) 81.4 Spain 5232 5.17 (4.98, 5.37) 80.7" exact="Denmark" post="804 5.08 (4.60, 5.62) 80.3 Finland 155 4.52 (3.72,"/>
  <result pre="5.17 (4.98, 5.37) 80.7 Denmark 804 5.08 (4.60, 5.62) 80.3" exact="Finland" post="155 4.52 (3.72, 5.56) 77.9    Rt (2â€&quot;4) Austria"/>
  <result pre="80.3 Finland 155 4.52 (3.72, 5.56) 77.9    Rt (2â€&quot;4)" exact="Austria" post="504 3.97 (3.56, 4.42) 74.8 Norway 996 3.74 (3.47,"/>
  <result pre="77.9    Rt (2â€&quot;4) Austria 504 3.97 (3.56, 4.42) 74.8" exact="Norway" post="996 3.74 (3.47, 4.04) 73.3 Portugal 112 3.68 (2.86,"/>
  <result pre="3.97 (3.56, 4.42) 74.8 Norway 996 3.74 (3.47, 4.04) 73.3" exact="Portugal" post="112 3.68 (2.86, 4.75) 72.8 Czech Republic 141 3.57"/>
  <result pre="3.74 (3.47, 4.04) 73.3 Portugal 112 3.68 (2.86, 4.75) 72.8" exact="Czech Republic" post="141 3.57 (2.88, 4.45) 72.0 Sweden 814 3.44 (3.20,"/>
  <result pre="(2.86, 4.75) 72.8 Czech Republic 141 3.57 (2.88, 4.45) 72.0" exact="Sweden" post="814 3.44 (3.20, 3.71) 70.9 United States 2294 3.29"/>
  <result pre="3.57 (2.88, 4.45) 72.0 Sweden 814 3.44 (3.20, 3.71) 70.9" exact="United States" post="2294 3.29 (3.15, 3.43) 69.6 Germany 3675 3.29 (3.18,"/>
  <result pre="(3.20, 3.71) 70.9 United States 2294 3.29 (3.15, 3.43) 69.6" exact="Germany" post="3675 3.29 (3.18, 3.40) 69.6 Switzerland 1139 3.26 (3.05,"/>
  <result pre="3.29 (3.15, 3.43) 69.6 Germany 3675 3.29 (3.18, 3.40) 69.6" exact="Switzerland" post="1139 3.26 (3.05, 4.78) 69.3 Brazil 151 3.26 (2.99,"/>
  <result pre="3.29 (3.18, 3.40) 69.6 Switzerland 1139 3.26 (3.05, 4.78) 69.3" exact="Brazil" post="151 3.26 (2.99, 3.55) 69.3 Netherlands 804 3.25 (3.02,"/>
  <result pre="3.26 (3.05, 4.78) 69.3 Brazil 151 3.26 (2.99, 3.55) 69.3" exact="Netherlands" post="804 3.25 (3.02, 3.51) 69.2 Greece 190 3.12 (2.67,"/>
  <result pre="3.26 (2.99, 3.55) 69.3 Netherlands 804 3.25 (3.02, 3.51) 69.2" exact="Greece" post="190 3.12 (2.67, 3.67) 67.9 France 3661 3.09 (2.99,"/>
  <result pre="3.25 (3.02, 3.51) 69.2 Greece 190 3.12 (2.67, 3.67) 67.9" exact="France" post="3661 3.09 (2.99, 3.19) 67.6 Israel 143 3.02 (2.56,"/>
  <result pre="3.12 (2.67, 3.67) 67.9 France 3661 3.09 (2.99, 3.19) 67.6" exact="Israel" post="143 3.02 (2.56, 3.59) 66.9 United Kingdom 798 2.90"/>
  <result pre="3.09 (2.99, 3.19) 67.6 Israel 143 3.02 (2.56, 3.59) 66.9" exact="United Kingdom" post="798 2.90 (2.72, 3.10) 65.5 Italy 17,660 2.44 (2.41,"/>
  <result pre="(2.56, 3.59) 66.9 United Kingdom 798 2.90 (2.72, 3.10) 65.5" exact="Italy" post="17,660 2.44 (2.41, 2.47) 59.0 Canada 198 2.30 (2.07,"/>
  <result pre="2.90 (2.72, 3.10) 65.5 Italy 17,660 2.44 (2.41, 2.47) 59.0" exact="Canada" post="198 2.30 (2.07, 2.57) 56.5 Iceland 134 2.28 (1.90,"/>
  <result pre="2.44 (2.41, 2.47) 59.0 Canada 198 2.30 (2.07, 2.57) 56.5" exact="Iceland" post="134 2.28 (1.90, 2.75) 56.1    Rt (1â€&quot;2) Iran"/>
  <result pre="56.5 Iceland 134 2.28 (1.90, 2.75) 56.1    Rt (1â€&quot;2)" exact="Iran" post="11,364 2.00 (1.96, 2.03) 50.0 Australia 199 1.86 (1.71,"/>
  <result pre="56.1    Rt (1â€&quot;2) Iran 11,364 2.00 (1.96, 2.03) 50.0" exact="Australia" post="199 1.86 (1.71, 2.03) 46.2 Belgium 559 1.75 (1.55,"/>
  <result pre="2.00 (1.96, 2.03) 50.0 Australia 199 1.86 (1.71, 2.03) 46.2" exact="Belgium" post="559 1.75 (1.55, 1.97) 42.9 Malaysia 197 1.74 (1.61,"/>
  <result pre="1.86 (1.71, 2.03) 46.2 Belgium 559 1.75 (1.55, 1.97) 42.9" exact="Malaysia" post="197 1.74 (1.61, 1.88) 42.5 Iraq 101 1.67 (1.41,1.97)"/>
  <result pre="1.75 (1.55, 1.97) 42.9 Malaysia 197 1.74 (1.61, 1.88) 42.5" exact="Iraq" post="101 1.67 (1.41,1.97) 40.1 Japan 734 1.49 (1.44, 1.54)"/>
  <result pre="197 1.74 (1.61, 1.88) 42.5 Iraq 101 1.67 (1.41,1.97) 40.1" exact="Japan" post="734 1.49 (1.44, 1.54) 32.9 Korea 8086 1.43 (1.42,"/>
  <result pre="1.49 (1.44, 1.54) 32.9 Korea 8086 1.43 (1.42, 1.45) 30.1" exact="Singapore" post="200 1.13 (1.06, 1.19) 11.5 Kuwait 100 1.06 (0.89,"/>
  <result pre="1.43 (1.42, 1.45) 30.1 Singapore 200 1.13 (1.06, 1.19) 11.5" exact="Kuwait" post="100 1.06 (0.89, 1.26) 5.66 Case study-3 Dong et"/>
  <result pre="for severe acute respiratory syndrome among healthcare workers in a" exact="Taiwan" post="hospitalJ Antimicrob Chemother56200591992216183666 56ZhouX.ZhaoM.WangF.JiangT.LiY.NieW.Epidemiologic features, clinical diagnosis and therapy"/>
 </snippets>
</snippetsTree>
